ABCD4 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.144500E-02 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.605000E-01 |
Normal-vs-Stage2 |
9.441600E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.286100E-02 |
Stage1-vs-Stage2 |
4.652000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.640500E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.910420E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.834100E-02 |
Normal-vs-AfricanAmerican |
8.944400E-03 |
Normal-vs-Asian |
8.515900E-03 |
Caucasian-vs-AfricanAmerican |
8.527200E-01 |
Caucasian-vs-Asian |
3.764600E-01 |
AfricanAmerican-vs-Asian |
2.686400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.191700E-02 |
Normal-vs-Female |
4.667600E-02 |
Male-vs-Female |
7.686800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.951600E-01 |
Normal-vs-Extreme_Weight |
3.848800E-01 |
Normal-vs-Obese |
1.410300E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.370600E-01 |
Normal_Weight-vs-Obese |
9.866200E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.925600E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.799800E-01 |
Normal-vs-Age(41-60Yrs) |
2.576800E-01 |
Normal-vs-Age(61-80Yrs) |
2.704400E-02 |
Normal-vs-Age(81-100Yrs) |
5.922800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.292000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.710200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.893200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.014800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.754400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.583200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.661800E-01 |
Normal-vs-Grade 3 |
3.047600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.800800E-01 |
Grade 2-vs-Grade 4 |
3.661800E-01 |
Grade 3-vs-Grade 4 |
3.047600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.028190E-01 |
Normal-vs-N1 |
9.659700E-02 |
N0-vs-N1 |
1.022380E-01 |
|
|